Lawsuit against FDA claims Bernie Sanders played role in approval of rival drug
February 17, 2020Research and Development, Sales and Marketing Bernie, Bernie Sanders, Catalyst Pharmaceuticals, FDA, TRUMP FDA, US FDA
Catalyst Pharmaceutical is attempting to show in court that pressure from US Senator Bernie Sanders led to the approval of …
Eisai releases new Phase 2 data for levatinib+everolimus combo in advanced kidney cancer
February 17, 2020Research and Development, Sales and Marketing Cancer, Eisai, Kidney cancer, Lenvima, pharma, renal cell carcinoma
New Phase 2 data has been revealed for Eisai’s Lenvima (levatinib), delivered alongside Novartis’ everolimus, for the treatment of unresectable …
Strong Phase 3 data for Takeda’s subcutaneous Entyvio in moderate to severe Crohn’s disease
February 17, 2020Research and Development, Sales and Marketing Crohn’s disease, Entyvio, Takeda, crohn's disease, pharma
Takeda has shared positive new Phase 3 data on a subcutaneous formulation of its gut-selective biologic Entyvio (vedolizumab) as a …
Experts call on NICE to recommended a ban on OTC codeine sales
February 17, 2020Research and Development, Sales and Marketing Codein, NICE, opioid crisis, opioids, prescription drugs
Experts have called for a ban on the sale of over the counter codeine as NICE is set to publish …
India considering export restrictions on antibiotics due to coronavirus
February 17, 2020Sales and Marketing Chinese Coronavirus, Indian Pharma, Wuhan, china coronavirus, coronavirus, drugs
The Indian government is considering an export ban on antibiotics, vitamins and hormones due to the lockdown of Hubei province, …
Top Ten most popular articles on Pharmafile.com this week
February 14, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, Chinese Coronavirus, Wuhan, Wuhan Coronavirus, china coronavirus, coronavirus
The coronavirus continues to dominate the news, with the disease finally getting treated. In America, a patient has been successfully …
Mumps cases in England rocket four-fold to highest point in a decade
February 14, 2020Medical Communications, Research and Development MMR vaccine, Vaccine, anti-vaccine, pharma
The incidence of mumps in the England has reached its highest level in 10 years, prompting warnings from health officials …
Global drug market’s production line threatened by coronavirus
February 14, 2020Medical Communications Chinese Coronavirus, Drug markets, Wuhan Coronavirus, china epidemic, coronavirus, drugs, epidemic, pharma
The global drug market is facing issues over production due to the coronavirus ravaging the supply line from China. In …
Eisai withdraws weight loss drug Belviq after FDA highlights cancer risk
February 14, 2020Medical Communications, Research and Development, Sales and Marketing Belviq, Eisai, FDA, pharma
The FDA has requested that Eisai withdraw its weight loss drug Belviq (lorcaserin) and Belviq XR from the US market …
Insulin pumps tied to over 2,000 injuries recalled
February 14, 2020Medical Communications Type 1 diabetes, diabetes, insulin, type 1, type 2, type 2 diabetes
Over 300,000 insulin pumps have been recalled by Medtronic after injuries and one death were reported due to devices malfunctioning. …
Sanofi axes four major players from its executive committee
February 13, 2020Manufacturing and Production, Medical Communications Sanofi, appointments, pharma
Sanofi has announced it will cull its executive committee under plans orchestrated by new Chief Executive Officer Paul Hudson, who …
Lilly and Incyte’s atopic dermatitis drug shows promise at Phase 3
February 13, 2020Sales and Marketing Eli Lilly, Incyte, baricitinib, pharma
Eli Lilly and Incyte have pulled back the curtain on Phase 3 data on their oral selective JAK inhibitor baricitinib …
Forecasts show branded generics will double in revenue with Asia driving growth
February 13, 2020Business Services branded drugs, drug patents, patents
Branded generic drugs are expected to grow in global sales by 8% by 2029, but Europe and America will not …
Highest fatalities from coronavirus recorded in a single day due to new classifications
February 13, 2020Business Services China, UK Coronavirus, Wuhan, Wuhan Coronavirus, coronavirus
The coronavirus outbreak reached its deadliest day since it began in December. Roughly 242 deaths have been reported in Hubei …
NICE does not recommend cancer drug combination to the NHS
February 13, 2020Business Services Cancer, Kidney cancer, NHS, NICE, keytruda, kidney disease
NICE has published draft guidance that does not recommend a new drug combination to combat untreated advanced renal cell carcinoma …
How do the Presidential frontrunners plan to combat the opioid crisis?
February 12, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2020 Election, Bernie, Bernie Sanders, Donald Trump, Joe, Joe Biden, Trump
The widespread addiction to extremely potent, legal painkillers has decimated the lives of millions across the United States. Overdoses from …
ICR identifies key “microRNA” gene driving chemotherapy resistance in cancer
February 12, 2020Research and Development Cancer, ICR, pharma
Researchers at the Institute of Cancer Research have discovered that a small RNA molecule known as microRNA gene MIR1249 contributes …
Type 2 diabetes drug Rosiglitazone increases risk of heart problems
February 12, 2020Research and Development British Medical Journal, diabetes, heart failure, insulin, type 2, type 2 diabetes
A new study has given further evidence that rosiglitazone can contribute to risk of heart problems and heart failure. The …
New report finds that health inequality in the UK greater than previously thought
February 12, 2020Research and Development NHS, NICE, type 2 diabetes
Men are living seven years in poor health while women are living nearly ten years, according to a new report. …
Seattle Genetics and Astellas unveil positive results for Padcev-Keytruda treatment for bladder cancer
February 12, 2020Research and Development Astellas, Cancer, Seattle Genentics, bladder, bladder cancer, keytruda, monotherapy
Seattle Genetics and Astellas reported positive results from their trials of Padcev plus Keytruda in treating bladder cancer. The data …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
